Lyme Disease: Diagnosis, Antibiotic Therapy, and Post-Treatment Syndromes

Clinical Guideline · Infectious Diseases

Lyme Disease: Diagnosis, Antibiotic Therapy, and Post-Treatment Syndromes

A practical framework for recognizing erythema migrans, applying two-tier serology in disseminated disease, and treating early, cardiac, neurologic, and arthritic manifestations per IDSA/AAN/ACR 2020 guidelines.

Author: gomdori, MD Specialty: Infectious Diseases Reading time: ~15 min
476KUS cases/year
>80%EM presentation
1–2%Lyme carditis
5–15%PTLDS after Rx

S1 · Pathophysiology and Epidemiology

Lyme disease is caused by spirochetes of the Borrelia burgdorferi sensu lato complex. B. burgdorferi sensu stricto predominates in North America; B. afzelii (skin manifestations) and B. garinii (neurologic manifestations) predominate in Europe. Transmission requires a minimum of 36–48 hours of attached tick feeding — risk is near zero if the tick is removed within 24 hours.

Tick Vectors

  • Ixodes scapularis (black-legged or deer tick) — vector in the northeastern and north-central US.
  • Ixodes pacificus — vector along the Pacific coast.
  • Ixodes ricinus — European vector.
  • Nymphal stage (May–July) is responsible for most human infections due to small size (poppy seed) and harder detection.

Geographic Distribution

95% of US cases occur in 14 states clustered in New England, mid-Atlantic, and upper Midwest (Connecticut, Massachusetts, Rhode Island, New Jersey, New York, Pennsylvania, Wisconsin, Minnesota). European hotspots include central and northern Europe, particularly Germany, Austria, Sweden, Slovenia, and the Baltic states. Climate change has expanded tick habitat northward into Canada.

Pathogenesis

After spirochete inoculation via tick saliva, Borrelia migrates outward through skin producing erythema migrans (EM). Hematogenous and lymphatic spread cause early disseminated disease with multiple EM lesions, Bell palsy, carditis, and meningitis over weeks. Late Lyme arthritis (typically monoarticular knee) develops months later and reflects persistent spirochete antigens plus autoimmune components. Genetic susceptibility (HLA-DR4) predicts antibiotic-refractory arthritis.

S2 · Clinical Stages and Classification

StageTimingKey Manifestations
Early localized3–30 days after biteSingle erythema migrans, flu-like symptoms
Early disseminatedWeeks–monthsMultiple EM, Bell palsy, meningitis, carditis, radiculoneuritis
LateMonths–yearsArthritis (large joint, monoarticular), encephalopathy, acrodermatitis chronica atrophicans (European)

Early Localized Disease — Erythema Migrans

EM is the pathognomonic early lesion — an expanding erythematous patch with central clearing ("bull's-eye") appearing 3–30 days after tick bite. Key features:

  • Size: ≥5 cm diameter (IDSA definition).
  • Morphology: erythematous, often with central clearing, occasionally with central vesicle/necrosis. Bull's-eye appearance in only 20% — uniform redness more common.
  • Location: thighs, groin, axillae, trunk (where ticks attach); rarely face.
  • Constitutional symptoms: fever, fatigue, headache, myalgia, arthralgia, regional lymphadenopathy.
  • Duration: untreated EM fades over 3–4 weeks.
Diagnostic pitfall: EM is a clinical diagnosis — do not order serology, which is often falsely negative in the first 1–2 weeks. Treat empirically based on typical lesion in endemic region.

Early Disseminated Disease

Occurs weeks to months after infection if untreated:

  • Multiple EM lesions (secondary EM): smaller, oval, scattered across body.
  • Cranial neuropathy: unilateral or bilateral facial palsy (Bell palsy) — Lyme causes 10% of facial nerve palsy in endemic areas and should trigger testing in relevant geography.
  • Meningitis / radiculitis: headache, photophobia, neck stiffness, radicular pain; CSF shows lymphocytic pleocytosis (<500 cells, mostly lymphocytes), mildly elevated protein, normal glucose.
  • Lyme carditis: AV block (first, second, or third degree) in 1–2%; myocarditis; rarely pericarditis.
  • Eye: conjunctivitis, uveitis, keratitis.

Late Lyme Disease

  • Lyme arthritis: monoarticular (60% knee) or oligoarticular, large-joint, intermittent episodes of joint swelling with moderate pain; more chronic in untreated cases. Synovial fluid shows inflammatory arthritis with 10,000–25,000 WBC/mm³, neutrophil-predominant.
  • Lyme encephalopathy: subtle cognitive symptoms (memory, concentration), rare in the US; distinct from PTLDS.
  • Acrodermatitis chronica atrophicans (ACA): B. afzelii-associated; progressive atrophic skin changes on extremities in Europe.

Lyme Carditis Severity

DegreePR / ECG FindingsDisposition
1° AV blockPR 200–300 msOutpatient oral; ECG monitoring
High-grade 1°PR >300 ms (still sinus conduction)Admit for telemetry + IV antibiotics
2° / 3° AV block or symptomaticMobitz I/II or complete heart block, syncope, chest painICU monitoring; IV ceftriaxone; temporary pacing available

S3 · Diagnostic Workup

When Serology Is Indicated

  • Not required: classic EM in endemic region (treat empirically).
  • Required: suspected disseminated or late Lyme (carditis, neuroborreliosis, arthritis), atypical skin lesion, patient outside endemic region.

Two-Tier Testing

Serology uses a two-step algorithm to balance sensitivity and specificity:

Standard Two-Tier Test (STTT):
  1. First tier: ELISA or IFA (screening, high sensitivity)
  2. Second tier: Western blot if first tier positive or equivocal
  3. IgM Western blot: ≥2 of 3 bands (23, 39, 41 kDa) positive — only valid <30 days since symptom onset
  4. IgG Western blot: ≥5 of 10 bands positive — valid any time
Modified Two-Tier Test (MTTT, CDC 2019 endorsed):
  1. First tier: VlsE-based EIA (highly sensitive)
  2. Second tier: different EIA (e.g., C6-peptide)
  3. Both must be positive → MTTT positive
  4. Higher sensitivity in early infection, equal specificity, no Western blot interpretation

Interpretation Nuances

  • Early localized: serology often negative for 2–4 weeks; do not wait for serology before treating EM.
  • Early disseminated: >80% IgM/IgG positive.
  • Late (arthritis, encephalopathy): nearly 100% IgG positive; IgG-negative essentially rules out late Lyme.
  • IgM alone after 30 days: likely false-positive; requires confirmatory IgG.
  • Antibodies persist years after successful treatment — serology cannot confirm cure. Do not retest as a "test of cure."

CNS Testing (Neuroborreliosis)

When neurologic manifestations are suspected, CSF studies support diagnosis:

  • Lymphocytic pleocytosis (typically 100–500 cells)
  • Elevated protein (50–150 mg/dL)
  • Normal glucose
  • CSF/serum Borrelia antibody index >1.0 (intrathecal antibody production) — confirmatory
  • CXCL13 chemokine elevation — emerging biomarker for active neuroborreliosis
  • PCR of CSF: low sensitivity (<20%)

Synovial Fluid Testing

In suspected Lyme arthritis:

  • Typical inflammatory joint fluid: 10,000–25,000 WBC/mm³ (range 500–100,000), neutrophil-predominant
  • PCR for Borrelia DNA: 70–85% sensitivity; excellent for ruling in but serum IgG is usually positive
  • Rule out septic arthritis if monoarticular with extremely elevated WBC (>50,000)

Tests to Avoid

Not endorsed by IDSA/CDC (avoid ordering):
  • Urine antigen testing
  • Lymphocyte transformation test
  • CD57 cell counts
  • "Bands-only" interpretation (positive IgM band 23 alone)
  • Direct microscopy of blood
  • Specialized "Lyme panels" from direct-to-consumer labs — high false-positive rates

Lyme disease

Treatment by stage

  1. ≤72 h after tick removal

    Post-exposure prophylaxis

    • Only if all: Ixodes scapularis, attached ≥36 h, local tick infection rate ≥20%
    • No contraindication: doxycycline 200 mg PO once
  2. 3⁠–⁠30 days after bite

    Solitary erythema migrans

    • Classic EM in endemic area: treat, no serology
    • Doxycycline 100 mg PO BID × 10 days, or amoxicillin 500 mg PO TID or cefuroxime 500 mg PO BID × 14 days
  3. Weeks to months

    Lyme carditis: 14⁠–⁠21 days in total

    • 1° AV block, PR <300 ms, asymptomatic: outpatient doxycycline 100 mg PO BID
    • PR >300 ms, 2°/3° AV block or symptoms (syncope, dyspnea, chest pain): admit, telemetry, ceftriaxone 2 g IV daily
    • Switch to oral doxycycline once PR <300 ms and stable
  4. Weeks to months

    Neuroborreliosis

    • Isolated facial palsy: doxycycline 100 mg PO BID × 14 days
    • Meningitis or radiculitis: ceftriaxone 2 g IV daily × 14 days
    • Encephalitis or myelitis: ceftriaxone 2 g IV daily × 14⁠–⁠21 days
  5. Months to years

    Lyme arthritis

    • Doxycycline 100 mg PO BID or amoxicillin 500 mg PO TID × 28 days
    • No or minimal response to oral course: ceftriaxone 2 g IV daily × 28 days

PTLDS: prolonged antibiotics are not effective and cause harm.

Pregnancy: doxycycline generally avoided; amoxicillin, cefuroxime or ceftriaxone preferred.

Adult doses. Sources: This article; IDSA/AAN/ACR 2020 guideline

S4 · Antibiotic Therapy (IDSA/AAN/ACR 2020)

Early Localized Disease (Erythema Migrans)

RegimenDoseDuration
Doxycycline (preferred)doxycycline 100 mg PO BID10 days
Amoxicillin (children <8, pregnancy)amoxicillin 500 mg PO TID (children: 50 mg/kg/day divided TID)14 days
Cefuroxime axetil (doxy intolerant)cefuroxime 500 mg PO BID14 days
Azithromycin (macrolide alternative)azithromycin 500 mg PO daily7 days (less effective; reserve for true beta-lactam and tetracycline allergy)
2020 IDSA update on doxycycline in children: Short-course doxycycline (≤21 days) is now considered safe in children under 8 years old — dental staining risk is negligible with short courses. Prior amoxicillin-first recommendation no longer strict. Doxycycline has the advantage of covering co-infecting Anaplasma phagocytophilum and Ehrlichia.

Disseminated Cutaneous (Multiple EM)

doxycycline 100 mg PO BID × 14 days (or amoxicillin/cefuroxime alternative).

Lyme Carditis

Stratify by severity:

  • Mild (1° AV block, PR <300 ms, asymptomatic): Outpatient doxycycline 100 mg PO BID × 14–21 days; daily ECG for first week.
  • High-grade or severe (PR >300 ms, Mobitz I/II, 3° block, or other arrhythmias; heart failure; or clinical manifestations of carditis or myopericarditis such as presyncope, syncope, pericarditic pain, shortness of breath, pericardial effusion, or elevated troponin): Hospital admission, telemetry, ceftriaxone 2 g IV daily × 14–21 days; transition to PO doxycycline once PR <300 ms and stable; have transcutaneous/transvenous pacing available; permanent pacemaker rarely needed — AV block resolves within 7 days of IV antibiotics in most cases.

Neuroborreliosis

SyndromePreferred RegimenAlternative
Isolated facial palsy (no CSF pleocytosis)doxycycline 100 mg PO BID × 14 days—
Meningitis / radiculitisceftriaxone 2 g IV daily × 14 daysDoxycycline 100 mg BID × 14 days (European non-severe)
Encephalitis / myelitisceftriaxone 2 g IV daily × 14–21 daysCefotaxime 2 g IV q8h; penicillin G 18–24 MU/day IV

Lyme Arthritis

  • First-line: doxycycline 100 mg PO BID × 28 days (or amoxicillin 500 mg TID × 28 days).
  • Partial response after the first oral course (mild residual joint swelling): the IDSA/AAN/ACR 2020 guideline makes no recommendation for a second antibiotic course versus observation; a second course of oral antibiotics for up to 1 month may be a reasonable alternative for patients in whom synovial proliferation is modest compared to joint swelling and for those who prefer repeating a course of oral antibiotics before considering IV therapy.
  • No or minimal response to the first oral course (moderate to severe joint swelling with minimal reduction of the joint effusion): a 2- to 4-week course of IV ceftriaxone, for example ceftriaxone 2 g IV daily × 28 days, is suggested over a second course of oral antibiotics.
  • Antibiotic-refractory Lyme arthritis (arthritis persists after one course of oral antibiotics and one course of IV antibiotics, HLA-DR4-associated): referral to a rheumatologist or other trained specialist is suggested for consideration of DMARDs (hydroxychloroquine, methotrexate), biologic agents, intra-articular steroids, or arthroscopic synovectomy.

Pregnancy

Amoxicillin 500 mg TID × 14 days (early localized) or ceftriaxone 2 g IV daily (disseminated) is preferred. Doxycycline traditionally avoided but short courses (≤14 days) increasingly considered acceptable for severe presentations per updated guidelines. No evidence of maternal-fetal transmission if treated promptly.

Jarisch-Herxheimer Reaction

Occurs in ~15% within 24 hours of first antibiotic dose: fever, chills, myalgia, exacerbation of EM or other symptoms. Self-limited; no need to discontinue therapy. Treat symptomatically with NSAIDs. Distinct from drug allergy.

S5 · Prophylaxis, Post-Treatment Syndrome, and Co-infections

Post-Exposure Prophylaxis

Single-dose doxycycline 200 mg PO × 1 dose reduces EM incidence by ~87% if ALL of the following are met:

  • Tick identified as nymphal or adult Ixodes scapularis
  • Tick attached ≥36 hours (engorged)
  • Prophylaxis started within 72 hours of tick removal
  • Local infection rate of Ixodes with Borrelia ≥20% (most of Northeast US qualifies)
  • No doxycycline contraindication

Prevention Counseling

  • Wear light-colored, long-sleeved clothing with pants tucked into socks
  • Apply DEET (20–30%), picaridin (20%), or permethrin-treated clothing
  • Perform full-body tick checks after outdoor activity; focus on groin, axillae, scalp, behind ears
  • Remove attached ticks with fine-tipped tweezers — grasp close to skin, steady upward pull; clean site with alcohol
  • Take hot shower within 2 hours of outdoor exposure (washes unattached ticks off)
  • Save tick in sealed bag with moist paper towel for identification if symptoms develop

Post-Treatment Lyme Disease Syndrome (PTLDS)

Defined as persistent/recurring fatigue, musculoskeletal pain, and cognitive complaints ≥6 months after completion of appropriate antibiotic therapy for confirmed Lyme disease. Affects 5–15% of treated patients.

Prolonged antibiotics are not effective and cause harm. Four randomized controlled trials (Klempner 2001, Krupp 2003, Fallon 2008, PLEASE trial 2016) showed no sustained benefit from extended IV ceftriaxone or oral antibiotic courses. Serious adverse events (line infections, C. difficile, cholelithiasis) occurred in up to 20% of extended IV treatment groups. Focus on symptom-directed care:
  • Cognitive behavioral therapy for pain and fatigue
  • Graded exercise
  • Treat depression, anxiety, sleep disorders
  • Rule out alternative diagnoses (fibromyalgia, chronic fatigue syndrome, depression, hypothyroidism, vitamin D/B12 deficiency, sleep apnea)

Tick-Borne Co-infections

Co-infectionVector OverlapClinical ClueTreatment
Anaplasmosis (A. phagocytophilum)Ixodes — same tickFever, leukopenia, thrombocytopenia, elevated LFTs; no rashDoxycycline 100 mg BID × 10 days
Babesiosis (Babesia microti)IxodesHemolytic anemia, fever, splenomegaly; severe in asplenia/immunocompromisedAtovaquone 750 mg BID + azithromycin 500 mg day 1, then 250 mg daily × 7–10 days
Powassan virusIxodesMeningoencephalitis; transmitted within 15 min of tick attachmentSupportive; no specific antiviral
Ehrlichiosis (E. chaffeensis)Amblyomma (lone star tick)Fever, leukopenia, thrombocytopenia, LFT elevationDoxycycline 100 mg BID × 10 days
Rocky Mountain spotted feverDermacentorFever + petechial rash (wrists/ankles first); high mortality if untreatedDoxycycline 100 mg BID × 7–10 days (empiric even in children)
When to refer to infectious diseases specialist: confirmed neuroborreliosis, Lyme carditis with high-grade AV block, antibiotic-refractory Lyme arthritis, treatment failure, pregnancy with confirmed Lyme, diagnostic uncertainty, PTLDS seeking repeated antibiotic courses, suspected co-infection, or immunocompromised host.

S6 · Practice Insights

(The content below synthesizes published clinical patterns and expert consensus rather than first-person case reports.)Antibody takes weeks to appear, so serology drawn during the erythema migrans rash reads negative in exactly the patients who have Lyme, and the testing and treatment rules — all center on three high-yield decisions: empiric treatment for erythema migrans without serology, the 4-6 week timing rule for two-tier testing in suspected disseminated disease, and the firm "no prolonged antibiotics for PTLDS" position that protects patients from harm despite their understandable desire for resolution. The four observations below capture how experienced clinicians navigate each.

What the Guideline Misses

The guidelines clearly state that erythema migrans in an endemic area is a clinical diagnosis requiring no serology, but in real practice seasoned clinicians see clinicians order Lyme serology in every suspected case before starting antibiotics, including patients with classic EM rash. Early Lyme serology has less than 50 percent sensitivity in the first 2-4 weeks because IgM and IgG responses have not yet developed. In experienced hands the EM rash plus appropriate exposure in an endemic area triggers immediate doxycycline 100 mg PO twice daily for 10 days, with no serology ordered. A negative serology in early disease does not exclude infection and routinely produces dangerous false reassurance.

Patterns That Repeat in Practice

The most consequential treatment error experienced clinicians see is prolonged antibiotic therapy for persistent symptoms after standard Lyme treatment, often labeled "chronic Lyme disease" by patients. Four well-conducted randomized controlled trials (Klempner 2001, Krupp 2003, Fallon 2008, Berende 2016) have demonstrated no benefit and substantial harm (catheter infections, C. difficile, drug toxicities) from prolonged antibiotic therapy in PTLDS. In experienced hands the conversation around PTLDS focuses on validation of the symptoms as real, structured symptomatic management (cognitive behavioral therapy, graded exercise, sleep hygiene, mood treatment), and explicit refusal of additional antibiotic courses regardless of patient pressure. This conversation is difficult but the alternative is patient harm.

Bedside Heuristic

experienced practitioners distinguish three syndromic categories in suspected disseminated Lyme that drive different antibiotic choices: cardiac (high-grade AV block, myopericarditis) requires intravenous ceftriaxone 2 g daily; isolated facial nerve palsy without other neurologic features can be treated with oral doxycycline; and meningitis, encephalomyelitis, or painful radiculitis require intravenous ceftriaxone 2 g daily for 14-28 days. The historical "any neurologic Lyme requires IV ceftriaxone" framing overtreats isolated facial palsy, which has equivalent outcomes with oral therapy per IDSA 2020 update.

What Experienced Practice Now Does Differently

experienced clinicians now offer single-dose doxycycline 200 mg orally as post-exposure prophylaxis for any patient with documented Ixodes scapularis tick bite of 36 or more hours duration in a high-prevalence area (Northeast and Upper Midwest US) with antibiotic given within 72 hours of tick removal. The historical reluctance to "treat without proven disease" is no longer evidence-supported — Nadelman 2001 NEJM trial demonstrated 87 percent reduction in EM development, and the single-dose approach has favorable cost-benefit and minimal adverse effect profile.

The Case That Cemented EM-Rash Empiric Treatment

A man in his early 50s presented to urgent care with a 7-day history of an expanding annular erythematous rash on his thigh with central clearing, fatigue, and low-grade fever. He had been camping in the Northeast US 2 weeks earlier. The covering clinician ordered two-tier Lyme serology and delayed antibiotic initiation pending results.

The first-tier ELISA returned negative 2 days later. The clinician reassured the patient that "Lyme was unlikely" and recommended symptomatic management for "presumed viral syndrome." The rash continued to expand and the patient developed bilateral facial nerve palsy 10 days later. At that point he was finally started on oral doxycycline, but he subsequently required a 21-day course of intravenous ceftriaxone for confirmed neuroborreliosis and had persistent facial weakness at 6-month follow-up.

What clinicians took from this case is that the EM rash plus appropriate exposure history is itself the diagnosis. Early Lyme serology has too low sensitivity to safely guide treatment decisions, and the false reassurance from a negative test in early disease can drive the trajectory toward disseminated complications. The clinical diagnosis of EM should trigger immediate antibiotic therapy without testing, full stop.

Takeaway: EM rash plus endemic exposure = clinical diagnosis = empiric doxycycline immediately. Do not order serology in early disease; the <50% sensitivity produces false reassurance and disseminated complications.

Four Deviations Seasoned Clinicians Make From the Standard Protocol

  1. EM rash empiric treatment, NO serology in early disease. Doxycycline 100 mg PO BID × 10 days at first visit for any EM rash in endemic area. Early serology <50% sensitivity produces false-negative reassurance.
  2. Two-tier MTTT serology ordered only at 4-6 weeks post-exposure, for suspected disseminated disease, NOT for early Lyme. Modified two-tier (two EIAs) per CDC 2019 has replaced the older immunoblot approach.
  3. Syndrome-specific antibiotic route for neurologic Lyme: isolated facial nerve palsy → oral doxycycline (IDSA 2020 update); meningitis/encephalomyelitis/radiculitis → IV ceftriaxone. The "all neuroborreliosis is IV" framing overtreats isolated CN VII palsy.
  4. Single-dose doxycycline 200 mg PEP for documented Ixodes bite ≥36 hr in high-prevalence area, within 72 hr of tick removal. Nadelman 2001 demonstrated 87% EM prevention. Refuse prolonged antibiotics for PTLDS — 4 RCTs negative, harm substantial.

S7 · Pearls, Pitfalls, and FAQ

✓ Pearl 1 — EM is a clinical diagnosis

In endemic regions, any expanding erythematous annular lesion ≥5 cm after tick exposure is Lyme until proven otherwise. Start doxycycline 100 mg BID × 10 days without serology. Waiting for ELISA risks progression and delays resolution. Photograph the rash — serial images document expansion and satisfy board-style exam questions.

✗ Pitfall 1 — Treating IgM-alone positive chronic symptoms

Positive IgM alone after >30 days of illness is almost always a false-positive. Chronic symptoms (>6 months) with IgM-positive/IgG-negative serology is not Lyme disease — do not prescribe antibiotics based on this pattern. Order IgG-confirmed two-tier testing and consider alternative diagnoses (fibromyalgia, chronic fatigue, depression, hypothyroidism).

✓ Pearl 2 — Get an ECG in every Lyme diagnosis

Early carditis can present subclinically. A 12-lead ECG at presentation detects asymptomatic PR prolongation and avoids an emergency room visit for syncope days later. PR >300 ms mandates admission and IV ceftriaxone.

✗ Pitfall 2 — Extending antibiotics for PTLDS

Four RCTs have disproven the "chronic Lyme" antibiotic hypothesis. Extended antibiotic courses (IV ceftriaxone >4 weeks, sequential oral-to-IV-to-oral) carry serious complications: central line bloodstream infections (1–3%), C. difficile, cholelithiasis (ceftriaxone-biliary sludge), and antibiotic resistance in household flora. Refer to multidisciplinary symptom management instead.

✓ Pearl 3 — Think co-infection in severe presentation

Severe fatigue + hemolytic anemia → check Babesia smear and PCR. Fever + leukopenia + thrombocytopenia → think Anaplasma or Ehrlichia. Doxycycline empirically covers Lyme, Anaplasma, Ehrlichia, and RMSF — one of the many reasons it is preferred over amoxicillin in adults.

✗ Pitfall 3 — Delaying tick removal

Home remedies (Vaseline, matches, alcohol) delay removal and increase regurgitation of spirochetes. Use fine-tipped tweezers grasping as close to the skin as possible, pull steadily upward without twisting. Don't panic about tick fragments — clean with alcohol and leave alone if embedded; the mouth parts don't transmit infection.

Patient Summary

What is Lyme disease? A bacterial infection spread by deer ticks. The classic sign is an expanding red rash (bull's-eye) 3–30 days after a bite. Untreated, it can cause heart block, Bell palsy, meningitis, and later arthritis.

Treatment: 10 days of doxycycline (an antibiotic) cures most early cases. Disseminated disease requires longer or IV antibiotics. Chronic "Lyme" treated with months of antibiotics is not supported by evidence and can cause serious harm.

Prevention: DEET spray, long pants tucked into socks, daily tick checks, prompt tick removal with tweezers. See a doctor if you develop a spreading rash, fever, or facial droop within 30 days of a tick exposure.

Frequently Asked Questions

Should clinicians order serology for a patient with erythema migrans?
No — erythema migrans is a clinical diagnosis alone, and early serology is often falsely negative because antibodies take 2 to 4 weeks to develop. Treat empirically with doxycycline 100 mg PO BID for 10 days in any patient with a typical EM lesion (≥5 cm expanding annular erythema) after tick exposure in endemic region. Serology is only useful for disseminated or late Lyme (carditis, neuroborreliosis, arthritis) where IgG should be positive. Ordering and acting on negative early serology delays treatment and risks progression.
What is the modified two-tier testing algorithm, and when should clinicians use C6 EIA?
The traditional two-tier test is ELISA (screening) followed by Western blot if positive/equivocal. The modified two-tier test (MTTT, CDC-endorsed 2019) uses two different EIAs instead: first a VlsE-based EIA (very sensitive), followed by a C6-peptide EIA if the first is positive. MTTT offers improved sensitivity in early infection and eliminates Western blot interpretation errors, while maintaining specificity. Use MTTT for routine testing in early disseminated or late Lyme disease. Both algorithms require confirmation of IgG positivity (IgM alone after 4 weeks is likely false-positive).
When should clinicians hospitalize a patient with Lyme carditis?
Hospitalize for IV ceftriaxone 2 g daily any Lyme carditis patient with: second- or third-degree AV block, PR interval >300 ms (high risk of progression to complete heart block), other arrhythmias, heart failure, or clinical manifestations of carditis or myopericarditis such as presyncope, syncope, dyspnea, chest pain, pericardial effusion, or elevated troponin. Telemetry monitoring is mandatory, and temporary transvenous pacing should be available for complete heart block. Most conduction defects resolve within 1 week of IV antibiotics, and permanent pacemakers are rarely needed. Transition to oral doxycycline 100 mg BID once PR <300 ms and symptoms resolved, completing 14-21 days total antibiotic course.

Leave a Reply

Your email address will not be published. Required fields are marked *